NCT01655589Unknown不适用
VEGF Gene Polymorphism and Response to Intravitreal Anti-VEGF Agents in Neovascular Age-related Macular Degeneration
Institute of Vision, Brasil1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2008年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 74
- 试验地点
- 1
研究概览
简要总结
The main purpose of this study is to investigate the association between VEGF gene polymorphism and the response to intravitreal drugs in neovascular age-related macular degeneration. This is a retrospective review of patients treated between 2008 and 2012 at the Institute of Vision, in Belo Horizonte, Brazil.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of neovascular age-related macular degeneration
- •Visual acuity better than 20/400
- •Loading dose with three intravitreal injections of anti-VEGF agents, administred one per month over three months
- •Follow-up period of at least six months
排除标准
- •Choroidal neovascularization secondary to any other cause than age-related macular degeneration
- •Eyes with polypoidal choroidal vasculopathy
- •Eyes previously submitted to posterior vitrectomy
- •Other diseases that could affect visual acuity
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Relationship Between the VEGF Gene Polymorphism and Cardiometabolic Risk FactorsPolymorphism, Restriction Fragment LengthNCT04077554Poznan University of Medical Sciences400
进行中（未招募）
不适用
Pilot study of association of VEGF polymorphisms with clinical efficacy and tolerability of therapy in patients affected by exudative (neovascular) age-related macular degeneration. - DEGENEExudative and atrophic age-related macular degeneration.MedDRA version: 6.1Level: PTClassification code 10025409EUCTR2007-004487-53-ITAZIENDA OSPEDALIERA PISANA
Unknown
不适用
Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus BevacizumabMetastatic Colorectal CancerNCT01363739Azienda Ospedaliero, Universitaria Pisana265
已完成
不适用
Polymorphism Interaction to Predict Bevacizumab EfficacyMetastatic Breast CancerNCT01935102University of Pisa169
Unknown
不适用
Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo TransferReproductive TechniquesNCT04261660Carmel Medical Center90